Hypofractionated Radiation Therapy Clinical Trials
24 recruitingRadiation
Phase 211Not Applicable7Phase 14Phase 33
Showing 1–20 of 24 trials
Recruiting
Phase 1Phase 2
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Stage III Pancreatic Cancer AJCC v8Locally Advanced Pancreatic Adenocarcinoma
National Cancer Institute (NCI)92 enrolled44 locationsNCT04172532
Recruiting
Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
NRG Oncology486 enrolled211 locationsNCT07097142
Recruiting
Phase 2
Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
Cervical CancerCervix CancerCervical Adenocarcinoma+2 more
Uganda Cancer Institute278 enrolled1 locationNCT07276360
Recruiting
Phase 2
Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma
Soft Tissue Sarcoma
Medical University of South Carolina40 enrolled1 locationNCT06905132
Recruiting
Not Applicable
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
Recurrent Adult Soft Tissue Sarcoma
Jonsson Comprehensive Cancer Center51 enrolled1 locationNCT02701153
Recruiting
Phase 2
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8+3 more
Mayo Clinic99 enrolled3 locationsNCT06078709
Recruiting
Not Applicable
Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
SchwannomaIntracranial NeoplasmGrade I Meningioma+4 more
Emory University70 enrolled1 locationNCT04278118
Recruiting
Not Applicable
An Evaluation of Dose-escalation for Intrathoracic Tumours
Lung Cancers
Chris Goodman141 enrolled3 locationsNCT06794125
Recruiting
Not Applicable
Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial
Ewing SarcomaRound Cell Sarcoma With EWSR1-non-ETS Fusion
Mayo Clinic141 enrolled1 locationNCT07188532
Recruiting
Phase 3
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
Stage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8Biochemically Recurrent Prostate Carcinoma+4 more
Mayo Clinic118 enrolled6 locationsNCT06205316
Recruiting
Phase 2
Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Study
Diffuse Midline Glioma, H3 K27M-Mutant
Mayo Clinic29 enrolled2 locationsNCT05077735
Recruiting
Phase 2
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Breast CarcinomaAnatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
Mayo Clinic120 enrolled1 locationNCT06635980
Recruiting
Phase 2
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma
Stage III Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8Stage IIIB Hepatocellular Carcinoma AJCC v8+4 more
Mary Feng, MD21 enrolled1 locationNCT04430452
Recruiting
Phase 2
Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-sen University134 enrolled1 locationNCT06912074
Recruiting
Phase 3
Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC
Locally Advanced Non-Small Cell Lung Cancer
Sun Yat-sen University311 enrolled3 locationsNCT07052669
Recruiting
Phase 1
Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)
Prostate CancerProstate Adenocarcinoma
University of Maryland, Baltimore18 enrolled1 locationNCT04486755
Recruiting
Phase 2
A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.
Soft Tissue Sarcoma
Institut Claudius Regaud48 enrolled11 locationsNCT06022159
Recruiting
Phase 1
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+6 more
Ohio State University Comprehensive Cancer Center28 enrolled2 locationsNCT05136846
Recruiting
Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer
Early Breast CancerDuctal Breast Carcinoma In Situ
National Taiwan University Hospital315 enrolled2 locationsNCT06984250
Recruiting
Not Applicable
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
Brain TumorGlioblastomaGlioma
University of Maryland, Baltimore32 enrolled5 locationsNCT04699773